Dave Coulier Says He's Thought of Death amid Cancer Struggle: 'I'm Prepared Either Way'
Full House’ alum Dave Coulier — who was diagnosed with stage 3 non-Hodgkin lymphoma — said that he’s thought about death ...
OK Magazine on MSN6h
'Full House' Alum Dave Coulier Is Cancer-Free After Bout With Non-Hodgkin Lymphoma
In an inspiring twist of fate, beloved actor Dave Coulier is sharing his triumphant health journey after battling stage 3 non ...
Dave Coulier Is Cancer-Free 5 Months After Being Diagnosed with Non-Hodgkin Lymphoma
Dave Coulier's cancer is in remission! A rep for the 65-year-old 'Full House' actor confirmed that he was cancer-free after a ...
The American Journal of Managed Care1d
Unique Challenges for Younger NHL Populations: Andrew Evens, DO
Adolescent and Young Adult Cancer Awareness Week serves as an opportunity to shed light on the special considerations and experiences of younger oncology patient populations.
mlive5d
‘Prepared to die,’ Dave Coulier beats Non-Hodgkin Lymphoma, gets cancer-free diagnosis
Dave Coulier and his “Full House” family are celebrating the announcement that he has beaten Non-Hodgkin Lymphoma. The actor ...
pharmaphorum4d
First drug backed for NHS use in untreated Hodgkin lymphoma
Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated ...
Non-Hodgkin’s Lymphoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...
FOX 10 Phoenix6d
Dave Coulier gives update on cancer battle, finishes chemotherapy
Dave Coulier, best known for Full House, recently opened up about his battle with stage 3 non-Hodgkin’s lymphoma in an ...
The National Institute for Health and Care Excellence4d
First-ever NHS treatment approved for advanced Hodgkin lymphoma
From today, adults with advanced Hodgkin lymphoma have access to a new treatment, after we recommended brentuximab vedotin (brand name Adcetris) in combination with other therapies for routine NHS use ...